Use of orlistat to treat chylous ascites: a case report

Jaime Chen,T. Hassanein
DOI: https://doi.org/10.1111/j.1572-0241.2003.08365.x
2003-09-01
Abstract:Orlistat, a potent lipase inhibitor that prevents fatty acid absorption, has been used effectively in the management of obesity. We present the first case describing the use of orlistat to treat chylous ascites. A 47 year-old Hispanic man with hepatitis C and alcohol cirrhosis was admitted with severe abdominal distention and dyspnea. He had a history of refractory ascites requiring serial paracentesis. Due to diabetes-associated renal insufficiency, he was on minimal diuretics. He was afebrile and stable. The physical exam demonstrated stigmata of chronic liver disease, decreased right breath sounds, and tense ascites. Blood tests showed a baseline chronic anemia, total bilirubin 2.2, INR 1.4, and albumin 1.4. Previously the ascitic fluid was clear with a high SAAG. On this admission however, the ascitic fluid was milky, pink-colored with triglyceride 585, total protein 0.7, albumin <0.1, RBC 8850, and WBC 300. He was concurrently found to have a new large right pleural effusion that was also milky in appearance with triglyceride 691. A nuclear medicine macroaggregated albumin study confirmed the chylothorax to be of hepatic origin. Extensive testing of the ascitic and pleural fluids showed negative cytology and cultures, including AFB. A colonoscopy and bone marrow biopsy were also normal. The chylous ascites and chylothorax were attributed to cirrhosis, and the patient was placed on a low-fat diet supplemented by medium chain triglycerides (MCT) oil. The chylous ascites and chylothorax responded poorly, however. It was later determined to be due to dietary noncompliance. In an effort to limit his dietary fat intake, orlistat was then started with each meal. The MCT oil was taken independently. After orlistat supplementation, the chylous ascites and chylothorax both resolved. Although the high volume ascites and hydrothorax persisted, the ascitic triglyceride fell to 66 and pleural effusion triglyceride fell to 247. After placement of a TIPS shunt, the ascites and pleural effusion completely resolved. Chylous ascites can have various causes, including cirrhosis. Irrespective of the cause, the traditional management has been a low-fat diet supplemented with MCT oil. As our case shows, however, this can be difficult to implement successfully even in a hospital setting. We demonstrated that in this situation orlistat can be used effectively as an aid to achieve a truly low-fat diet.
What problem does this paper attempt to address?